Lawyers in a patient injury lawsuit accusing Medtronic of wrongdoing over a pain pump that left a man paralyzed renew their arguments after the case was opened for a re-hearing.

Medical device industry giant Medtronic (NYSE:MDT) is back in court this month for a re-hearing of a patient injury trial accusing the company of wrongdoing that left an Arizona man paralyzed.

Lawyers traded barbs in court this week as the plaintiff argued that Medtronic had failed to properly provide product updates the FDA that would have earlier warned physicians and patients about potential issues with the medical device company's SynchroMed programmable pain pump implant.